Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis : A Small Case Series Using Streptokinase
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Seminars in thrombosis and hemostasis - 47(2021), 4 vom: 30. Juni, Seite 431-435 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Caballero López, Armando [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 14.06.2021 Date Revised 14.06.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/s-0040-1716872 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319428656 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319428656 | ||
| 003 | DE-627 | ||
| 005 | 20231225171427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/s-0040-1716872 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1064.xml |
| 035 | |a (DE-627)NLM319428656 | ||
| 035 | |a (NLM)33378782 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Caballero López, Armando |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis |b A Small Case Series Using Streptokinase |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.06.2021 | ||
| 500 | |a Date Revised 14.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 650 | 7 | |a Recombinant Proteins |2 NLM | |
| 650 | 7 | |a Streptokinase |2 NLM | |
| 650 | 7 | |a EC 3.4.- |2 NLM | |
| 650 | 7 | |a itolizumab |2 NLM | |
| 650 | 7 | |a XQQ2RHV14N |2 NLM | |
| 700 | 1 | |a Herrera Cartaya, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Chávez González, Elibet |e verfasserin |4 aut | |
| 700 | 1 | |a González Reinoso, Delvis |e verfasserin |4 aut | |
| 700 | 1 | |a Caballero Font, Jorge Alain |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez Vera, Naivi |e verfasserin |4 aut | |
| 700 | 1 | |a Nápoles Lizano, Mario E |e verfasserin |4 aut | |
| 700 | 1 | |a Vázquez Roque, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Morales Valdera, Alexis |e verfasserin |4 aut | |
| 700 | 1 | |a Crombet Ramos, Tania |e verfasserin |4 aut | |
| 700 | 1 | |a Betancourt Cervantes, Julio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in thrombosis and hemostasis |d 1975 |g 47(2021), 4 vom: 30. Juni, Seite 431-435 |w (DE-627)NLM000434361 |x 1098-9064 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2021 |g number:4 |g day:30 |g month:06 |g pages:431-435 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0040-1716872 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2021 |e 4 |b 30 |c 06 |h 431-435 | ||